PLCG2 and colorectal carcinoma: First, we need to expand the sample size of the clinical cohort by enrolling more CRC patients and further evaluate the clinical value of PLCG2 as an effective biomarker and therapeutic target for CRC in future multicenter prospective clinical studies.